Keyword: Food and Drug Administration (FDA)

News

EU approves Novartis Drug for More Cancers

06.06.2016 - The European Commission has granted approval for Novartis’ Afinitor (everolimus) for treating unresectable or metastatic, well-differentiated non-functional neuroendocrine tumors...

News

Opdivo from BMS Wins Another US Approval

24.05.2016 - The US Food and Drug Administration (FDA) has approved Bristol-Myers Squibb’s (BMS) cancer drug, Opdivo, to treat classical Hodgkin Lymphoma (HL). The approval is the eighth for...

News

Genentech’s Bladder Cancer Drug Wins US Approval

23.05.2016 - Genentech has won an accelerated approval from the US Food and Drug Administration (FDA) for bladder cancer treatment Tecentriq. The immunotherapy has been cleared to treat...

News

Breakthrough Status for Keytruda in Blood Cancer

22.04.2016 - US drugmaker Merck has gained Breakthrough Therapy Designation (BTD) from the US Food and Drug Administration (FDA) for Keytruda to treat patients with classical Hodgkin lymphoma...

News

FDA Approves Drug for Leukemia Subset

22.04.2016 - After giving it a priority review in January, the US Food and Drug Administration (FDA) has approved Venclexta (venetoclax), a novel of drug that targets a subset of leukemia...

News

Gilead Buys Nimbus Hepatitis Program

07.04.2016 - US drug maker Gilead Sciences is to pay $400 million to Nimbus Therapeutics for its subsidiary Nimbus Apollo and its Acetyl-CoA Carboxylase (ACC) inhibitor program. The ACC program...

Markets & Companies

After Pharma’s Patent Cliff

04.04.2016 - Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...

News

US Group Advocates Clinical Trials Update

31.03.2016 - Pointing to deaths in clinical drug trials every month since December 2015 worldwide, the US Center for Responsible Science (CRS), a nonprofit advocacy group pushing for “more...